Protein conformation and disease

Veterinary Research

Volumn 27, Issue 4-5, 1996, Pages 373-382

  Nandi, P K ^a  

^a CEMAGREF   (France)

Author keywords

Alzheimer; Neurodegenerative disease; Prion protein detection; Protein conformation; Therapy; protein

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL DISEASE; CHEMISTRY; GENETICS; HUMAN; MACROMOLECULE; METABOLISM; NEUROLOGIC DISEASE; POINT MUTATION; PRION; PRION DISEASE; PROTEIN SECONDARY STRUCTURE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; MACROMOLECULAR SUBSTANCES; NERVOUS SYSTEM DISEASES; POINT MUTATION; PRION DISEASES; PRIONS; PROTEIN STRUCTURE, SECONDARY;

EID: 0030358840     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Braak H, Braak E (1991) Alzheimer's disease affects nuclei of the thalamus. Acta Neuropathol 81, 261-268
2. Brown P (1992) Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with codon 178 Asn PRNP mutation. Ann Neurol 31, 282-285
3. Castano EM, Frangione B (1988) Human amyloidosis, Alzheimer disease and related disorders. Lab Invest 58, 122-137
4. Caughey B, Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease and phospholipase sensitive J Biol Chem 266, 18217-18223
5. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS (1991) Secondary structure analysis of the scrapie associated protein PrP 27-30 in water by infrared strectroscopy. Biochemistry 30, 7072-7080
6. Chatlier-Haslin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor gene. Nature (London) 353, 844-846
7. Cohen AS, Skinner M (1990) New frontiers in the study of amyloidosis. N Engl J Med 323, 542-543
8. De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW (1986) Reciprocal changes in corticoprotein releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer disease Nature (London) 319, 593-
9. Diringer H (1992) Hidden amyloidoses. Exp Clin Immunogenet 9, 212-229
10. Forloni G, Angretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment Nature (London) 367, 543-545
11. Frangione B (1989) Systemic and cerebral amyloidosis. Ann Med 21, 69-77
12. Gasset M, Baldwin MA, Lyod D, Gabriel JM, Holtzmann DM, Cohen F, Fletterick R, Prusiner SB (1992) Predicted α-helical regions of the prion protein when synthesized as peptides forms amyloid. Proc Natl Acad Sci USA 89, 10940-10944
13. Gasset M, Baldwin MA, Flettrick RJ, Prusiner SB (1993) Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA 90, 1-5
14. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Connelly PM, Dlouhy SR, Azzarelli B (1989) Gerstmann-Straussler-Scheinker disease II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39, 1453-1461
15. Ghiso J, Haltia M, Prelli F, Novello J, Frangione B (1990) Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 272, 827-830
16. Goedert M, Jakes R, Crauther RA, Six J, Lübke U, Vandermeeren M, Crass P, Trojanowski JO, Lee VMY (1993) The abnormal phosphorylation of tau protein at ser-202 in Alzheimer disease recapitulates phosphorylation during development Proc Natl Acad Sci USA 90, 5066-5070
17. Goldfarb LG, Mitrova E, Brown P, Toh BH, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia Lancet 336, 514-515
18. Goldfarb LG, Brown P, Haltia M, Ghiso J, Frangione B, Gajdusek DC (1993) Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc Natl Acad Sci USA 90, 4451-4454
19. Goldgaber D, Lerman MJ, McBride OW, Saffotti U, Gajdusek DC, (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimers's disease Science 235, 877-880
20. Goldgaber D, Goldfarb LG, Brown P, Asher DM, Brown WT, Lin S, Teener JW, Feinstone SM, Rubenstein R, Kasesak RJ, (1989) Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler Scheinker's syndrome. Exp Neurol 106, 204-206
21. Groate A, Chartier-Haslin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature (London) 349, 704-706
22. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1991) Linkage of prion protein missense: variant to Gerstmann-Straussler syndrome. Nature (London) 338, 342-345
23. Hsiao K, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hoder ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangler. Nature Genetics 1, 68-71
24. Hsiao KK, Growth D, Scott M, Yang SL, Serban H, Rapp D, Foster D, Torchia M, DeArmond SJ, Prusiner SB (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91, 9126-9130
25. Hunter N (1992) Scrapie in sheep and goats. In: Progress in Sheep and Goat Research (AW Speedy, ed), CAB International, Wallingford, UK, 131-151
26. Jarret JT, Berger EP, Lansbuty Jr PT (1993) The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implication for the pathogenesis of Alzheimer's disease Biochemistry 32, 4693-4697
27. Joachim CL, Duffy L, Morris JH, Selkoe DJ (1988) Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res 474, 100-111
28. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Mulltaup G, Beyreuther K, Müllendill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor Nature (London) 325, 733-736
29. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue N, Katayana S, Kawakamis H, Nakamura S, Nishimura M, Akiguchi (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome. Nature (Genetics) 8, 221-227
30. Medori R, Tritschler HJ, Leblanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagne P, Cortelli P (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326, 444-449
31. Merlini G, Ascari E, Amboldi N, Belloti V, Arbustini E, Perfetti V, Ferrari M, Zorzoli I, Marionone MG, Garini P, Diegoli M, Trizio D, Ballinari D (1995) Interaction of the anthracycline 4′-iodo-4′-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA 92, 2959-2963
32. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Linn YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimers's disease. Arch Biochem Biophys 301, 41-52
33. Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid β-protein in Alzheimers's disease. J Biol Chem 267, 17802-17806
34. Murray CPJ, Nurmiaho-Lassila EL (1992) Creation of amyloid fibrils from mutant Asm 187 gelsolin peptides. Biochem Biophys Res Commun 183, 227-231
35. Murrell J, Farlow M, Chetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99
36. Nandi PK, Robinson DR (1972) The effects of salts on the free energy of the peptide group. J Am Chem Soc 95, 1299-1308
37. Naruse S, Igarashi S, Aoki K, Kanesco K, Iihara K, Miyataki T, Kobayashi H, Inuzuka T, Shinzu T, Koïma T, Tsuji S (1991) Mis-sense mutation Val → IIe in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337, 978-979
38. Nguyen J, Baldwin MA, Cohen FE, Prusiner SB (1995) Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochemistry 34, 4186-4192
39. Ozel M, Diringer H (1994) Small virus-like structure in fractions from scrapie hamster brain. Lancet 343, 894-895
40. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorm I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of α-helix into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90, 10962-10966
41. Perutz M (1994) Polar zippers: their role in human disease. Protein Sci 3, 1629-1637
42. Price DL, Borchelt DR, Sisodia SS (1993) Alzheimer's disease and the prion disorders amyloid β-protein and prion protein amyloidoses. Proc Natl Acad Sci USA 90, 6381-6384
43. Prusiner SB (1992) Chemistry and biology of prions. Biochemistry 31, 12277-12288
44. Prusiner SB (1994) Biology and genetics of prion diseases. Ann Rev Microbiol 48, 655-686
45. Robakis NK, Ramakrishne N, Wolfe G, Wisneiski HM (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84, 4190-4194
46. Rohwer RG (1991) The scrapie agent: 'a virus by any other name'. Curr Top Microbiol Immunol 172, 195-232
47. Safar J, Wang W, Padgett MP, Ceroni M, Piccardo P, Zopf D, Gajdusek DC, Gibbs Jr CJ (1990) Molecular mass, biochemical composition and physicochemical behaviour of the infectious form of the scrapie precursor protein monomers. Proc Natl Acad Sci USA 87, 6373-6377
48. Safar J, Roller PP, Gajdusek DC, Gibbs Jr CJ (1994) Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33, 8375-8383
49. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME, Potter H, Heston LL, Martin JM (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 661-668
50. Schmerr MJ, Goodwin KR, Cutlip RC (1994) Capillary electrophoresis of the scrapie prion protein from sheep brain. J Chromatogr A 680, 447-453
51. Selkoe DJ (1991) The molecular pathology of Alzheimers's disease Neuron 6, 487-498
52. Shyng SL, Heuser JE, Harris DA (1994) A glycolipid-anchored prion protein is endocytosed via clathrin coated pits. J Cell Biol 125, 1239-1250
53. Soto C, Castano EM, Frangione B, Inestrosa NC (1995) The α-helical to β-strand transition in the amino terminal fragment of the amyloid β-peptide modulates amyloïd formation. J Biol Chem 270, 3063-3067
54. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991-2000
55. Stott K, Blackburn JM, Butler PJG, Perutz (1995) Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative disease. Proc Natl Acad Sci USA 92, 6509-6513
56. Tagliavini F, Prelli F, Verga L, Giaccone G, Sarma R, Gorevic P, Ghetti B, Passerini F, Ghibaudi E, Forloni G, Salmona M, Bugiani O, Frangione B (1993) Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90, 9678-9682
57. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St-George-Hyslop P, Vankeuren ML, Patterson D, Pagan S, Kurmit DM, Neve RL (1987) Amyloid β protein gene cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235, 880-884
58. Taraboulous A, Scott M, Semenov A, Avraham D, Laszlo L, Prusiner SB (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129, 121-132
59. Weidemann A, Konig G, Bunke D, Fischer P, Salbaumm JM, Masters CL, Beyreuther K (1989) Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein Cell 57, 115-126
60. Wisniewski T, Ghiso J, Frangione B (1991) Peptide homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 179, 1247-1254
61. Yanker BA, Mesulam MM (1991) β-amyloid and the pathogenesis of Alzheimers disease. N Engl J Med 325, 1849-1857